Disease-Vaccine-Landing-Page/Pneumococcal/vaccine-injury

According to the CAPVAXIVE (PCV21) package insert, in pre-licensing clinical trials, the most commonly reported side effects following vaccination included injection site pain, redness and swelling, muscle pain, headache, and...

As of December 27, 2024, there have been 28,316 serious adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) in connection with pneumococcal vaccinations (PCV7, PCV13, PCV15, PCV20,...

According to the PCV20 package insert, in pre-licensing clinical trials, the most commonly reported side effects following vaccination in children 15 months of age and younger who received four doses...

All pre-licensing clinical safety trials of PCV15 in adults compared the vaccine to PCV13. In clinical trials, common side effects reported following vaccination included injection site pain, redness, and swelling,...

According to the CDC, approximately 50 percent of individuals who receive the pneumococcal polysaccharide vaccine (PPSV23) experience pain and redness at the injection site. Muscle aches, fever, and more severe...

Adverse reactions following administration of PCV13 differed by dose in the series and age of the recipient. In children, the most commonly reported reactions included irritability, drowsiness, loss of appetite,...